Skip to content

[Webinar] Why modernizing hemorrhagic stroke workflows can’t wait
Featuring: Sabareesh Natarajan, MD, MS
Thursday, May 14, 2 PM PT

Register
  • There are no suggestions because the search field is empty.
  • There are no suggestions because the search field is empty.
Press Release

RapidAI Celebrates International Adoption of AI-Powered Stroke Care

The company today announced unprecedented growth in the adoption and use of the Rapid platform around the world with nearly 300% growth.

Share to

The company today announced unprecedented growth in the adoption and use of the Rapid platform around the world with nearly 300% growth.

San Mateo, Calif. — November 12, 2020 — RapidAI, the leader in advanced imaging for stroke, today announced unprecedented growth in the adoption and use of the Rapid platform around the world. Now approved in over 60 countries and utilized in over 1,600 hospitals, the company has experienced a year-over-year increase in just International Rapid scans (outside the U.S.) of nearly 300%, comparing Q3 2019 to Q3 2020. RapidAI makes the most-widely used advanced cerebrovascular imaging products for patient care, research, and clinical trials across the globe. RapidAI clinical products help save lives, RapidAI workflow and messaging technologies help stroke teams save time, and RapidAI analytics and business intelligence products help stroke networks reduce costs and improve patient outcomes. “The number of people who suffer a stroke worldwide each year is staggering, over fifteen million,” offered Marc Hofmans RapidAI Senior Vice President of Sales, EMEA. “While it is no small task, our mission is to bring AI-powered stroke imaging to every corner of the globe. With Rapid now in more than 60 countries, we are well on our way.” After celebrating the one-millionth Rapid scan in July of this year, RapidAI now reports that it is on an accelerating run-rate to deliver one-million scans in 2020, alone. With the goal of saving lives and improving the outcomes for more and more patients, RapidAI is also on track to reach the major milestone of a million total patients scanned by the end of this year. RapidAI International Growth Rapid in use in over 1,600 hospitals worldwide Rapid now in more than 60 countries 298% growth in Rapid scans, outside the U.S., (Q3 2019 to Q3 2020) 275% growth in patients scanned with Rapid, outside the U.S., (Q3 2019 to Q3 2020) Run-rate to deliver one-million Rapid scans worldwide in 2020 On track to scan a total of one-million patients worldwide, with Rapid, by the end of 2020 “ I see artificial intelligence as the future in the fast-moving world of diagnostic and therapeutic stroke management,” said Dr. Sanjeev Nayak, Royal Stoke NHS UK. “Using AI will help stroke victims when 'Time Is Brain'. RapidAI has helped stroke patients by providing positive insight to the treating clinicians by accelerating stroke diagnosis. This ensures accurate therapeutic intervention in the shortest possible time after the onset of stroke. ” Rapid is the only clinically validated platform available and considered by many to be the gold standard for advanced cerebrovascular imaging. To learn more visit www.RapidAI.com . About RapidAI RapidAI is the worldwide leader in advanced imaging for stroke. Based on intelligence gained over 1,000,000 scans from more than 1,600 hospitals in over 60 countries, the Rapid® platform uses artificial intelligence to create high quality, advanced images from non-contrast CT, CT angiography, CT perfusion, and MRI diffusion and perfusion scans. The Rapid imaging platform includes Rapid ICH, Rapid ASPECTS, Rapid CTA, Rapid LVO, Rapid CTP, and Rapid MRI. RapidAI also offers SurgicalPreview®, a comprehensive aneurysm management platform. RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients using clinically-proven, data-driven technology. With our validated, trusted products developed by medical experts, clinicians worldwide are improving patient care and outcomes every day. For more information, visit RapidAI.com.

Contact PR

Jessica Stebing

Jessica Stebing

Group Manager, Marketing Communications

stebing@rapidai.com

Get to know Rapid in the real world

View All Resources
Video - Lumina Webinar Replay

Webinar

The end of manual head & neck reconstructions // A faster path with Lumina 3D

In this webinar, we focus on the challenges and opportunities in 3D head and neck CTA reconstruction workflows. Our speakers share real-world insights on how the Lumina 3D platform can have a tangible impact on CT workflow, scanner throughput, and diagnosis.
Radiology Rewired Podcast - Episode 1 Thumbnail

Podcast

AI Meets Imaging | Radiology Rewired | Ep. 1

In the debut episode of Radiology Rewired, RapidAI’s new clinician-led podcast hosted by Dr. Singh, Dr. Greg Albers—founder of RapidAI and professor of neurology at Stanford University—shares the story behind one of medicine’s most important breakthroughs: extending the stroke treatment window to 24 hours. Dr. Albers recounts how decades of imaging research led from early diffusion-perfusion MRI to automated AI tools that changed global stroke guidelines and transformed how teams diagnose and treat patients. This episode explores how deep clinical AI is reshaping radiology and why credible, clinician-led innovation remains essential for the next generation of healthcare technology.
Resources - multistakeholder white paper

White paper

The clinical AI champion's guide: getting to "yes" in complex health systems

This guide is designed for internal champions, clinicians, service line leaders, and administrators who believe in the potential of AI to improve care and operations. It offers practical insights from a C-suite advisory panel from leading health systems across the nation on how decisions are made, who typically drives them forward, and what tools and strategies are proving most effective in securing alignment and buy-in across the system.